[go: up one dir, main page]

UA94628C2 - Humanized monoclonal antibody that binds to steap-1 and use thereof - Google Patents

Humanized monoclonal antibody that binds to steap-1 and use thereof

Info

Publication number
UA94628C2
UA94628C2 UAA200905270A UAA200905270A UA94628C2 UA 94628 C2 UA94628 C2 UA 94628C2 UA A200905270 A UAA200905270 A UA A200905270A UA A200905270 A UAA200905270 A UA A200905270A UA 94628 C2 UA94628 C2 UA 94628C2
Authority
UA
Ukraine
Prior art keywords
steap
monoclonal antibody
humanized monoclonal
binds
antibody
Prior art date
Application number
UAA200905270A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Майкл С. Деннис
Бонни РУБИНФЕЛД
Пол Полакис
Айя Якобовиц
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of UA94628C2 publication Critical patent/UA94628C2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to a humanized monoclonal antibody that specifically binds to STEAP-1. The invention further relates to a method of detecting the presence of STEAP- a biological sample, an immunoconjugate comprising the antibody, a pharmaceutical formulation, a method of inhibiting cellular proliferation etc.
UAA200905270A 2006-10-27 2007-10-26 Humanized monoclonal antibody that binds to steap-1 and use thereof UA94628C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86329506P 2006-10-27 2006-10-27

Publications (1)

Publication Number Publication Date
UA94628C2 true UA94628C2 (en) 2011-05-25

Family

ID=41232249

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200905270A UA94628C2 (en) 2006-10-27 2007-10-26 Humanized monoclonal antibody that binds to steap-1 and use thereof

Country Status (4)

Country Link
CN (1) CN101573384B (en)
SI (1) SI2061814T1 (en)
UA (1) UA94628C2 (en)
ZA (1) ZA200902161B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11180571B2 (en) 2017-04-03 2021-11-23 Hoffmann-La Roche Inc. Antibodies binding to STEAP-1

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185430A1 (en) * 2010-06-03 2012-12-28 Genentech Inc Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
WO2012025525A1 (en) * 2010-08-24 2012-03-01 Roche Glycart Ag Activatable bispecific antibodies
JP5933562B2 (en) * 2010-09-29 2016-06-15 シアトル ジェネティックス， インコーポレイテッド N-carboxyalkyl-auristatin and uses thereof
EP4458859A3 (en) * 2012-04-04 2025-01-22 Perseus Proteomics Inc. Conjugate of anti-cdh3 (p-cadherin) antibody and drug
RU2016130349A (en) * 2014-01-24 2018-03-01 Дженентек, Инк. WAYS OF APPLICATION OF ANTIBODIES AGAINST STEAP1 AND IMMUNOCONJUGATES
ES2764110T3 (en) * 2014-04-25 2020-06-02 Pf Medicament Antibody-drug conjugate and its use for cancer treatment
CN107029242A (en) 2015-11-03 2017-08-11 财团法人工业技术研究院 Antibody drug complex and method for producing same
US11173214B2 (en) 2015-11-25 2021-11-16 Legochem Biosciences, Inc. Antibody-drug conjugates comprising branched linkers and methods related thereto
CN107167541B (en) * 2017-07-08 2019-08-02 万舒（北京）医药科技有限公司 The method for measuring the DTPA-Zn in rat plasma biological sample
EP3790591A4 (en) 2018-05-09 2022-05-11 LegoChem Biosciences, Inc. COMPOSITIONS AND METHODS RELATED TO ANTI-CD19 ANTIBODY-DRUG CONJUGATES
WO2020063676A1 (en) 2018-09-26 2020-04-02 江苏恒瑞医药股份有限公司 Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof
KR102503143B1 (en) * 2019-03-06 2023-02-24 주식회사 레고켐 바이오사이언스 Antibody-drug conjugate comprising antibody against human DLK1 and its use
CN116063516A (en) 2019-04-01 2023-05-05 江苏恒瑞医药股份有限公司 anti-Claudin18.2 antibodies and uses thereof
JP2022539344A (en) 2019-06-26 2022-09-08 江蘇恒瑞医薬股▲ふん▼有限公司 Anti-CEA antibody and its application
KR20220057575A (en) * 2019-09-05 2022-05-09 메모리얼 슬로안 케터링 캔서 센터 Anti-STEAP1 antibodies and uses thereof
JP7467610B2 (en) 2019-09-18 2024-04-15 バイリ－バイオ（チェンドゥ）ファーマスーティカル シーオー．，エルティーディー． Camptothecin derivatives and their complexes
JP2023532197A (en) 2020-06-30 2023-07-27 江蘇恒瑞医薬股▲ふん▼有限公司 Anti-CD70 antibody and its application
TW202304983A (en) 2020-10-14 2023-02-01 大陸商江蘇恆瑞醫藥股份有限公司 Anti-her3 antibody, anti-her3 antibody-drug conjugate and pharmaceutical use thereof
CN112924665B (en) * 2021-02-19 2023-10-03 山东莱博生物科技有限公司 Antibody horseradish peroxidase marker and preparation and application thereof
AU2021225125B9 (en) 2021-07-19 2023-02-02 Mabplex International Co., Ltd. Antibody drug conjugate loaded with binary toxins and its application
CN117295526A (en) * 2021-09-10 2023-12-26 上海药明合联生物技术有限公司 Method for preparing highly homogeneous antibody-drug conjugates of engineered antibodies
TW202423928A (en) 2022-09-02 2024-06-16 美商默沙東有限責任公司 Exatecan-derived topoisomerase-1 inhibitors pharmaceutical compositions, and uses thereof
WO2024129628A1 (en) 2022-12-14 2024-06-20 Merck Sharp & Dohme Llc Auristatin linker-payloads, pharmaceutical compositions, and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012187A (en) * 2004-04-22 2007-03-28 Agensys Inc Antibodies and molecules derived therefrom that bind to steap-1 proteins.
ES2669510T3 (en) * 2004-09-23 2018-05-28 Genentech, Inc. Antibodies and conjugates engineered with cysteine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11180571B2 (en) 2017-04-03 2021-11-23 Hoffmann-La Roche Inc. Antibodies binding to STEAP-1
US11685790B2 (en) 2017-04-03 2023-06-27 Hoffmann-La Roche Inc. Antibodies binding to STEAP-1
US12129306B2 (en) 2017-04-03 2024-10-29 Hoffman-La Roche Inc. Antibodies binding to STEAP-1

Also Published As

Publication number Publication date
CN101573384B (en) 2013-02-20
ZA200902161B (en) 2010-06-30
CN101573384A (en) 2009-11-04
SI2061814T1 (en) 2012-09-28

Similar Documents

Publication Publication Date Title
UA94628C2 (en) Humanized monoclonal antibody that binds to steap-1 and use thereof
HRP20181565T1 (en) Monoclonal antibodies against claudin-18 for treatment of cancer
NO20071436L (en) Humanized Anti-5T4 Antibodies and Anti-5T4 Antibody / Calicheamicin Conjugates
NO20083891L (en) Anti-5T4 antibodies and uses thereof
NZ611269A (en) Neutralizing anti-ccl20 antibodies
BRPI0818437A2 (en) Antibody or functional fragment of the antibody, pharmaceutical composition, use of at least one of the antibodies or functional fragments of the antibodies, and hybridoma
MY145058A (en) Prlr-specific antibody and uses thereof
UA106194C2 (en) Diagnosis and treatment of cancer using anti-ereg antibody
MX2009004532A (en) Compositions and methods for binding sphingosine-1-phosphate.
IL197928A (en) Humanized monoclonal antibody that binds to steap-1, immunoconjugates and uses thereof
TW200639182A (en) Antibody variants and uses thereof
AR057807A1 (en) ANTI-CD3 ANTIBODY FORMULATIONS
UA95958C2 (en) Antibody that binds to cd22, immunoconjugates and uses therefor
DE602006013029D1 (en) ANTI-EGFR ANTIBODY
MX2009006034A (en) Antagonist antibodies against ephb3.
UA106529C2 (en) CXCR4 HUMANIZED ANTIBODY FOR CANCER TREATMENT
BRPI1005176A2 (en) insulin assay, insulin assay reagent, monoclonal antibody, and method of screening monoclonal antibodies.
WO2011053565A3 (en) Compositions and methods for detecting a tauopathy
UA99292C2 (en) Antibody which specifically binds to neuropilin-2b (nrp2b)
MY146366A (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
MX2009001341A (en) Ephb3-specific antibody and uses thereof.
PH12013500432A1 (en) Anti-vegfr-3 antibody compositions
BR112012002248A2 (en) antibody making method, humanized antibody making method, use of an antibody and pharmaceutical composition
UA98100C2 (en) Humanized monoclonal antibody that binds and neutralizes human nogo
UA96426C2 (en) Isolated human or humanized antibody that specifically binds to il-13